Vagal blocking improves glycemic control and elevated blood pressure in obese subjects with type 2 diabetes mellitus
Shikora S, Toouli J, Herrera MF, Kulseng B, Zulewski H, Brancatisano R, Kow L, Pantoja JP, Johnsen G, Brancatisano A, et al.
Journal of Obesity · 2013
Key finding
In 28 obese subjects with type 2 diabetes, open-label vagal blocking therapy produced 25% excess weight loss and a 1.0% reduction in HbA1c at 12 months.
Auto-extracted · verification pendingHow we verify
- Condition
- Obesity
- Stimulation
- iVNS
- Evidence tier
- Controlled Clinical Trial
- Participants
- 28
Share this study
Download the citation card as a PNG, or copy a link to this page.
Cite this study
Shikora, S., Toouli, J., Herrera, M. F., Kulseng, B., Zulewski, H., Brancatisano, R., Kow, L., Pantoja, J. P., Johnsen, G., Brancatisano, A., Tweden, K. S., Knudson, M. B., & Billington, C. J. (2013). Vagal blocking improves glycemic control and elevated blood pressure in obese subjects with type 2 diabetes mellitus. Journal of Obesity, 2013, 1-8. https://doi.org/10.1155/2013/245683
Related studies in Obesity
Effect of vagus nerve stimulation on metabolism: a systematic review and meta-analysis
Shen et al. · International journal of obesity (2005) · 2025 · Systematic Review / Meta-Analysis
Effects of auricular stimulation on weight- and obesity-related parameters: a systematic review and meta-analysis of randomized controlled clinical trials
Hua et al. · Frontiers in neuroscience · 2024 · Systematic Review / Meta-Analysis
Vagal Nerve Therapy in the Management of Obesity: A Systematic Review and Meta-Analysis
Fadel et al. · European Surgical Research · 2023 · Systematic Review / Meta-Analysis
Effect of Vagal Nerve Blockade on Moderate Obesity with an Obesity-Related Comorbid Condition: the ReCharge Study
Morton et al. · Obesity Surgery · 2016 · Randomised Controlled Trial
Summary by Vagus Research. Always consult the primary source for the authoritative record.